Exercise Stress Testing: Indications and Common Questions

 

Exercise stress testing is a validated diagnostic test for coronary artery disease in symptomatic patients, and is used in the evaluation of patients with known cardiac disease. Testing of asymptomatic patients is generally not indicated. It may be performed in select deconditioned adults before starting a vigorous exercise program, but no studies have compared outcomes from preexercise testing vs. encouraging light exercise with gradual increases in exertion. Preoperative exercise stress testing is helpful for risk stratification in patients undergoing vascular surgery or who have active cardiac symptoms before undergoing nonemergent noncardiac surgery. Exercise stress testing without imaging is the preferred initial choice for risk stratification in most women. Sensitivity and specificity increase with the use of adjunctive imaging such as echocardiography or myocardial perfusion imaging with single-photon emission computed tomography. Exercise stress testing is rarely an appropriate option to evaluate persons with known coronary artery disease who have no new symptoms less than two years after percutaneous intervention or less than five years after coronary artery bypass grafting. The Duke treadmill score has excellent prognostic value for exercise stress testing. Imaging is not necessary if patients are able to achieve more than 10 metabolic equivalents on exercise stress testing. Exercise stress testing is not indicated before noncardiac surgeries in patients who can achieve 4 metabolic equivalents without symptoms.

Exercise stress testing is used to detect inducible cardiac ischemia in symptomatic intermediate-risk patients who can exercise and who have interpretable electrocardiography results.1  Risk is determined by American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines for stable ischemic heart disease or the Diamond and Forrester score to assess pretest probability of coronary artery disease (CAD; Table 1).1,2

 Enlarge     Print

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendationEvidence ratingReferences

Preoperative exercise stress testing for risk stratification before noncardiac surgery is not indicated if the patient is able to achieve 4 or more metabolic equivalents without symptoms.

C

1, 5

Exercise stress testing is helpful for risk stratification in patients undergoing vascular surgery and in those who have active cardiac symptoms before undergoing nonemergent noncardiac surgery.

C

1, 5

Exercise stress testing is not recommended in asymptomatic patients to screen for coronary artery disease.

C

3, 6, 7

Adjunctive imaging increases cost without improving prognostic value in patients who can achieve more than 10 metabolic equivalents during exercise stress testing.

B

19, 21


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendationEvidence ratingReferences

Preoperative exercise stress testing for risk stratification before noncardiac surgery is not indicated if the patient is able to achieve 4 or more metabolic equivalents without symptoms.

C

1, 5

Exercise stress testing is helpful for risk stratification in patients undergoing vascular surgery and in those who have active cardiac symptoms before undergoing nonemergent noncardiac surgery.

C

1, 5

Exercise stress testing is not recommended in asymptomatic patients to screen for coronary artery disease.

C

3, 6, 7

Adjunctive imaging increases cost without improving prognostic value in patients who can achieve more than 10 metabolic equivalents during exercise stress testing.

B

19, 21


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

 Enlarge     Print

BEST PRACTICES IN CARDIOLOGY: RECOMMENDATIONS FROM THE CHOOSING WISELY CAMPAIGN

RecommendationSponsoring organization

Do not perform stress cardiac imaging or advanced noninvasive imaging in the initial evaluation of patients without cardiac symptoms unless high-risk markers are present.

American College of Cardiology

Do not perform cardiac imaging for patients who are at low risk.

American Society of Nuclear Cardiology

Avoid using stress echocardiography on asymptomatic patients who meet low-risk scoring criteria for coronary disease.

American Society of Echocardiography

Avoid cardiovascular stress testing for patients undergoing low-risk surgery.

Society for Vascular Medicine

Patients who have no cardiac history and good functional status do not require preoperative stress testing before noncardiac thoracic surgery.

Society of Thoracic Surgeons

Do not obtain baseline diagnostic cardiac testing or cardiac stress testing in asymptomatic stable patients with known cardiac disease (e.g., coronary artery disease, valvular disease) undergoing low- or moderate-risk noncardiac surgery.

American Society of Anesthesiologists

Do not perform routine annual stress testing after coronary artery revascularization.

Society of Nuclear Medicine and Molecular Imaging


Source: For more information on the Choosing Wisely Campaign, see http://www.choosingwisely.org. For supporting citations and to search Choosing Wisely recommendations relevant to primary care, see https://www.aafp.org/afp/recommendations/search.htm.

BEST PRACTICES IN CARDIOLOGY: RECOMMENDATIONS FROM THE CHOOSING WISELY CAMPAIGN

RecommendationSponsoring organization

Do not perform stress cardiac imaging or advanced noninvasive imaging in the initial evaluation of patients without cardiac symptoms unless high-risk markers are present.

American College of Cardiology

Do not perform cardiac imaging for patients who are at low risk.

American Society of Nuclear Cardiology

Avoid using stress echocardiography on asymptomatic patients who meet low-risk scoring criteria for coronary disease.

American Society of Echocardiography

Avoid cardiovascular stress testing for patients undergoing low-risk surgery.

Society for Vascular Medicine

Patients who have no cardiac history and good functional status do not require preoperative stress testing before noncardiac thoracic surgery.

Society of Thoracic Surgeons

Do not obtain baseline diagnostic cardiac testing or cardiac stress testing in asymptomatic stable patients with known cardiac disease (e.g., coronary artery disease, valvular disease) undergoing low- or moderate-risk noncardiac surgery.

American Society of Anesthesiologists

Do not perform routine annual stress testing after coronary artery revascularization.

Society of Nuclear Medicine and Molecular Imaging


Source: For more information on the Choosing Wisely Campaign, see http://www.choosingwisely.org. For supporting citations and to search Choosing Wisely recommendations relevant to primary care, see https://www.aafp.org/afp/recommendations/search.htm.

 Enlarge     Print

Table 1.

Diamond and Forrester Score for Pretest Probability of Coronary Artery Disease

Age (years)SexTypical/definite angina pectorisAtypical/probable angina pectorisNonanginal chest pain

≤ 39

Male

Intermediate

Intermediate

Low

Female

Intermediate

Very low

Very low

40 to 49

Male

High

Intermediate

Intermediate

Female

Intermediate

Low

Very low

50 to 59

Male

High

Intermediate

Intermediate

Female

Intermediate

Intermediate

Low

≥ 60

Male

High

Intermediate

Intermediate

Female

High

Intermediate

Intermediate


note: Typical angina is defined as having all of the following: substernal chest pain or discomfort, provocation by exertion or emotional stress, and relief with rest or nitroglycerin. Atypical angina has two of the three characteristics. Nonanginal chest pain may have one or none.

High = > 90% pretest probability, intermediate = 10% to 90%, low = 5% to 10%, very low = < 5%.

Adapted with permission from Wolk MJ, Bailey SR, Doherty JU, et al.; American College of Cardiology Foundation Appropriate Use Criteria Task Force. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;63(4):388, with additional information from reference 2.

Table 1.

Diamond and Forrester Score for Pretest Probability of Coronary Artery Disease

Age (years)SexTypical/definite angina pectorisAtypical/probable angina pectorisNonanginal chest pain

≤ 39

Male

Intermediate

Intermediate

Low

Female

Intermediate

Very low

Very low

40 to 49

Male

High

Intermediate

Intermediate

Female

Intermediate

Low

Very low

50 to 59

Male

High

Intermediate

Intermediate

Female

Intermediate

Intermediate

Low

≥ 60

Male

High

Intermediate

Intermediate

Female

High

Intermediate

Intermediate


note: Typical angina is defined as having all of the following: substernal chest pain or discomfort, provocation by exertion or emotional stress, and relief with rest or nitroglycerin. Atypical angina has two of the three characteristics. Nonanginal chest pain may have one or none.

High = > 90% pretest probability, intermediate = 10% to 90%, low = 5% to 10%, very low = < 5%.

Adapted with permission from Wolk MJ, Bailey SR, Doherty JU, et al.; American College of Cardiology Foundation Appropriate Use Criteria Task Force. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;63(4):388, with additional information from reference 2.

The standard Bruce protocol is preferred for exercise stress testing3  (eTable A). Its outcomes are well validated, and exercise capacity measured in metabolic equivalents (METs) has good prognostic value. The Bruce protocol can be modified for patients with predicted poor exercise capacity by adding two warm-up stages before the first stage. The Naughton protocol allows for a more gradual increase in exertion and uses shorter stages, increasing the likelihood of diagnostic results in older and deconditioned patients.3 This article reviews indications for and answers common questions about exercise stress testing.

 Enlarge     Print

eTable A.

Common Treadmill Protocols for Exercise Stress Testing

ProtocolMiles per hourGrade (%)Metabolic equivalents

Standard Bruce protocol (3 minutes per stage)

Stage 1

1.7

10

4

Stage 2

2.5

12

7

Stage 3

3.4

14

10

Stage 4

4.2

16

13

Stage 5

5.0

18

16

Stage 6

5.5

20

NA

Stage 7

6.0

22

NA

Modified Bruce protocol (3 minutes per stage)

Stage 1

1.7

0

2

Stage 2

1.7

5

3

Stage 3

1.7

10

4

Stage 4

2.5

12

7

Stage 5

3.4

14

10

Stage 6

4.2

16

13

Stage 7

5.0

18

16

Stage 8

5.5

20

NA

Stage 9

6.0

22

NA

Naughton protocol (2 minutes per stage)

Stage 1

1.0

0

1

Stage 2

2.0

0

2

Stage 3

2.0

3.5

3

Stage 4

2.0

7

4

Stage 5

2.0

10.5

5

Stage 6

2.0

14

6

Stage 7

2.0

17.5

7


NA = not available.

Information from Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873934.

eTable A.

Common Treadmill Protocols for Exercise Stress Testing

ProtocolMiles per hourGrade (%)Metabolic equivalents

Standard Bruce protocol (3 minutes per stage)

Stage 1

1.7

10

4

Stage 2

2.5

12

7

Stage 3

3.4

14

10

Stage 4

4.2

16

13

Stage 5

5.0

18

16

Stage 6

5.5

20

NA

Stage 7

6.0

22

NA

Modified Bruce protocol (3 minutes per stage)

Stage 1

1.7

0

2

Stage 2

1.7

5

3

Stage 3

1.7

10

4

Stage 4

2.5

12

7

Stage 5

3.4

14

10

Stage 6

4.2

16

13

Stage 7

5.0

18

16

Stage 8

5.5

20

NA

Stage 9

6.0

22

NA

Naughton protocol (2 minutes per stage)

Stage 1

1.0

0

1

Stage 2

2.0

0

2

Stage 3

2.0

3.5

3

Stage 4

2.0

7

4

Stage 5

2.0

10.5

5

Stage 6

2.0

14

6

Stage 7

2.0

17.5

7


NA = not available.

Information from Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873934.

What Are the Indications for Exercise Stress Testing?

Exercise stress testing is commonly used for the detection of CAD in patients with chest pain or dyspnea on exertion who are at intermediate risk of acute coronary syndrome. Exercise stress testing reduces costs of hospitalization without worsening outcomes in patients presenting to the emergency department with chest pain and negative cardiac enzymes. Additional indications for exercise stress testing include prediction of cardiovascular events, assessment of chronotropic competence, evaluation of exercise-induced symptoms, evaluation of unexplained syncope in patients at intermediate to high risk of CAD, and assessment of response after medical or surgical interventions in patients with valve disease, arrhythmias, or other heart diseases. Consensus opinion from the ACCF/AHA is that exercise stress testing can be used for exercise prescriptions, but data on patient-oriented outcomes are lacking.

EVIDENCE SUMMARY

The AHA states that early exercise stress testing in emergency departments and chest pain units is safe, accurate, and cost-effective because of fewer hospital admissions.3 In a prospective cohort study of 3,552 patients in chest pain units who had low Diamond and Forrester scores, none had a positive stress test.4 Another study evaluated intermediate-risk patients presenting to the emergency department who had no known CAD and in whom acute coronary syndrome was excluded with two negative cardiac enzyme tests performed six hours apart.2 Exercise stress testing stratified intermediate-risk patients to a near zero short-term risk of acute coronary syndrome. A retrospective analysis of 3,987 patients younger than 40 years who were at intermediate risk of CAD and in whom myocardial infarction (MI) had been excluded found that exercise stress testing was of minimal value given the 0.4% incidence of positive findings.5

Preoperative exercise stress testing is not indicated for risk stratification before non-cardiac surgery in patients who are able to achieve a minimum of 4 METs (e.g., walking up one flight of stairs) without cardiac symptoms, even if they have a history of CAD.1,5 Exercise stress testing is helpful for risk stratification in patients undergoing vascular surgery and in those who have active cardiac symptoms before undergoing nonemergent noncardiac surgery.1,5 Patients with poor functional capacity (unable to achieve 4 METs) should undergo stress echocardiography or exercise single-photon emission computed tomography (SPECT) before undergoing vascular surgery or a kidney or liver transplant.1

Activities greater than 6 METs are associated with an increased risk of acute coronary syndrome. Experts recommend that deconditioned patients with diabetes mellitus, men older than 45 years or women older than 55 years, and those with two or more risk factors for CAD undergo exercise stress testing before starting a vigorous exercise program. However, no studies have compared outcomes from preexercise stress testing vs. encouraging light exercise with gradual increases in exertion.3

When Should Exercise Stress Testing Not Be Used?

Exercise stress testing is generally inappropriate for detection of ischemia in asymptomatic patients with no history of revascularization. Absolute contraindications include MI in the previous two days, ongoing unstable angina, uncontrolled cardiac arrhythmia with hemodynamic compromise, and symptomatic severe aortic stenosis (Table 2). 1,3 One in 10,000 exercise stress tests results in sudden cardiac death or hospitalization.

 Enlarge     Print

Table 2.

Contraindications to Exercise Stress Testing

Absolute contraindications

Active endocarditis

Acute aortic dissection

Acute myocarditis/pericarditis

Decompensated heart failure

Inability to exercise

Myocardial infarction in previous two days

Ongoing unstable angina

Symptomatic severe aortic stenosis

Uncontrolled cardiac arrhythmia with hemodynamic compromise

Relative contraindications

Acquired complete heart block (left bundle branch block)

Hypertrophic obstructive cardiomyopathy with severe resting gradient

Known left main coronary artery disease

Recent stroke or transient ischemic attack

Resting systolic blood pressure > 200 mm Hg or diastolic blood pressure > 110 mm Hg

Tachyarrhythmia with uncontrolled ventricular rate


Adapted with permission from Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):876, with additional information from reference1.

Table 2.

Contraindications to Exercise Stress Testing

Absolute contraindications

Active endocarditis

Acute aortic dissection

Acute myocarditis/pericarditis

Decompensated heart failure

Inability to exercise

Myocardial infarction in previous two days

Ongoing unstable angina

Symptomatic severe aortic stenosis

Uncontrolled cardiac arrhythmia with hemodynamic compromise

Relative contraindications

Acquired complete heart block (left bundle branch block)

Hypertrophic obstructive cardiomyopathy with severe resting gradient

Known left main coronary artery disease

Recent stroke or transient ischemic attack

Resting systolic blood pressure > 200 mm Hg or diastolic blood pressure > 110 mm Hg

Tachyarrhythmia with uncontrolled ventricular rate


Adapted with permission from Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):876, with additional information from reference1.

EVIDENCE SUMMARY

Testing asymptomatic patients without a history of revascularization is not recommended.1,3 The U.S. Preventive Services Task Force recommends against testing low-risk patients and found insufficient evidence for those at intermediate and high risk.6 The American Academy of Family Physicians supports this recommendation.7 A randomized controlled trial of asymptomatic patients 50 to 75 years of age who had type 2 diabetes and no known CAD found that screening with adenosine-stress radionuclide myocardial perfusion imaging did not reduce nonfatal MIs or cardiac deaths over five years compared with no screening.8 Testing patients with no new symptoms less than two years after percutaneous coronary intervention or less than five years after coronary artery bypass grafting is rarely appropriate.1

What Is the Diagnostic Value of Exercise Stress Testing with and Without Imaging for CAD?

Exercise stress testing is often better at excluding CAD than confirming it. Testing without imaging is the primary initial choice for risk stratification for most women and men. Imaging is best used when there is a baseline abnormality in resting electrocardiography that would make interpretation of results difficult, if the patient has symptoms at rest, if anatomic cardiac features require evaluation, or if it is likely that the test results would be nondiagnostic (e.g., in patients with poor exercise tolerance due to severe osteoarthritis) and that further testing would be required. Adjunctive imaging is required in patients taking digitalis because of the high false-positive rate of exercise stress testing alone in these patients.

EVIDENCE SUMMARY

Stress echocardiography and exercise SPECT are appropriate in symptomatic patients at intermediate or high risk of CAD and in those with difficult-to-interpret electrocardiography results.1 Symptomatic patients with a history of percutaneous coronary intervention or coronary artery bypass grafting should undergo exercise SPECT, stress echocardiography, or coronary angiography as clinically indicated.1

A 2012 systematic review of 34 prospective studies found that exercise stress testing and stress echocardiography were better at excluding CAD than confirming it (likelihood ratio [LR] of ruling out CAD via exercise stress testing = −0.34; 95% confidence interval [CI], 0.28 to 0.41; LR for stress echocardiography = −0.24; 95% CI, 0.17 to 0.32).9 Of the two testing modalities, stress echocardiography was better at ruling in CAD (LR = 7.94 vs. 3.57 for exercise stress testing).9  Sensitivity and specificity for CAD detection increase when imaging is performed with exercise stress testing (Table 3).1014 The prevalence of severe CAD is higher in older patients; exercise stress testing has a sensitivity of 84% in this population but a decreased specificity of 70%.3 SPECT is no better at detecting severe CAD than exercise stress testing, but it stratifies more intermediate-risk patients as low risk.15 SPECT is superior to echocardiography for attaining images diagnostic for CAD in obese patients and in those with chronic obstructive pulmonary disease.16

 Enlarge     Print

Table 3.

Summary of Tests for Detection of Coronary Artery Disease

TestSensitivity (%)Specificity (%)LimitationsAdvantages

Cardiac catheterization

98

82

Invasive, requires radiation

Preferred test, allows for detection and intervention

Exercise single-photon emission computed tomography

85

85

Cannot assess myocardium or valves, heart rhythm irregularities may affect results, soft tissue attenuation artifacts, requires radiation

Assesses myocardial perfusion and regional/global function at rest and during stress, good prognostic data and negative predictive value

Exercise stress testing

68

77

Requires normal baseline electrocardiography, not recommended for patients with history of percutaneous coronary intervention or coronary artery bypass grafting

Less expensive, limited equipment required, good prognostic data and negative predictive value

Stress echocardiography

79

87

Image quality affected by body habitus and dependent on operator, limited time for imaging postexercise

Assesses cardiac structure, global and segment function at rest and during stress, relatively inexpensive, does not require radiation, good prognostic data and negative predictive value


Information from references 10 through 14.

Table 3.

Summary of Tests for Detection of Coronary Artery Disease

TestSensitivity (%)Specificity (%)LimitationsAdvantages

Cardiac catheterization

98

82

Invasive, requires radiation

Preferred test, allows for detection and intervention

Exercise single-photon emission computed tomography

85

85

Cannot assess myocardium or valves, heart rhythm irregularities may affect results, soft tissue attenuation artifacts, requires radiation

Assesses myocardial perfusion and regional/global function at rest and during stress, good prognostic data and negative predictive value

Exercise stress testing

68

77

Requires normal baseline electrocardiography, not recommended for patients with history of percutaneous coronary intervention or coronary artery bypass grafting

Less expensive, limited equipment required, good prognostic data and negative predictive value

Stress echocardiography

79

87

Image quality affected by body habitus and dependent on operator, limited time for imaging postexercise

Assesses cardiac structure, global and segment function at rest and during stress, relatively inexpensive, does not require radiation, good prognostic data and negative predictive value


Information from references 10 through 14.

A randomized controlled trial of symptomatic women at intermediate risk of CAD showed no difference in event-free survival over two years of follow-up between those undergoing exercise stress testing vs. exercise SPECT.17 However, exercise stress testing costs less. Systematic reviews show that because the median prevalence of CAD in women is less than that in men, a positive result on exercise stress testing indicates a lower probability of CAD (69% vs. 89%); however, negative results in women have better negative predictive value.9 Exercise stress testing without imaging is the preferred initial choice for risk stratification in women.

In a 2014 randomized controlled trial comparing exercise stress testing alone and exercise stress testing with myocardial perfusion imaging, 965 patients younger than 65 years who had no known CAD, normal resting electrocardiography, and symptoms of CAD underwent exercise stress testing for risk stratification. Per the provisional exercise stress testing protocol, if they achieved maximal predicted heart rate or greater than 10 METs of exercise with a clinically and electrically negative exercise stress test result, no imaging was performed.18 All-cause mortality was similar between those who underwent imaging and those who did not. No cardiac deaths occurred in those who underwent exercise stress testing alone.

Which Patients May Be Safely Risk Stratified with Exercise Stress Testing Alone?

Persons who achieve greater than 10 METs on exercise stress testing have an excellent prognosis, with a low prevalence of significant ischemia or CAD mortality. Further imaging in these patients increases cost without increasing prognostic benefit.

EVIDENCE SUMMARY

Patients with Duke exercise treadmill scores greater than 7 have a five-year survival rate of 93% compared with 67% for those with scores less than −11.19 METs are the only treadmill-associated variable significantly related to all-cause mortality.20 Decreased exercise capacity is associated with increased risk of MI, unstable angina, and coronary revascularization.21 A 1-MET increase in peak period treadmill workload was associated with an 18% reduction in cardiac events in patients older than 65 years and a 14% reduction in younger patients.22 Achievement of more than 10 METs on exercise stress testing equates to a low risk of death, regardless of imaging results.22 A prospective study of 7,236 patients without known dilated cardiomyopathy or moderate valvular disease who achieved more than 10 METs on stress echocardiography found less than 1% CAD mortality per person-year of follow-up, regardless of the presence of wall motion abnormalities on exertion.23 Similarly, patients who achieved at least 10 METs on exercise SPECT had an annualized cardiac mortality rate of 0.1% and combined cardiac death and nonfatal MI rate of 0.4%.20 This suggests that when at least 10 METs are achieved, further imaging increases cost without increasing prognostic benefit.20,23

What Findings on Exercise Stress Testing Warrant Termination and Further Evaluation?

ST-segment elevation of more than 1 mm without preexisting Q waves is an absolute indication for termination of exercise stress testing, whereas a horizontal or downsloping depression of more than 2 mm measured 60 to 80 milliseconds after the J-point is a relative indication (Table 4).3 Evidence of chronotropic incompetence by the inability of a patient's systolic blood pressure (BP) to rise above or drop below the resting systolic BP increases the risk of cardiovascular events.24 A decrease in systolic BP of more than 10 mm Hg with other evidence of ischemia is an absolute indication to terminate testing. An isolated decrease in systolic BP is a relative indication.

 Enlarge     Print

Table 4.

Indications for Termination of Exercise Stress Testing

Absolute indications

Central nervous system symptoms (e.g., ataxia, dizziness, near syncope)

Decrease in systolic blood pressure greater than 10 mm Hg despite an increase in workload and accompanied by other evidence of ischemia

Moderate to severe angina

Signs of poor perfusion (e.g., cyanosis, pallor) ST-segment elevation (> 1.0 mm) in leads without preexisting Q waves because of prior myocardial infarction (other than aVR, aVL, and V1)

Sustained ventricular tachycardia or other arrhythmia (including second- or third-degree atrioventricular block) that interferes with normal maintenance of cardiac output during exercise

Technical difficulties in monitoring electrocardiography or systolic blood pressure

The patient asks to stop

Relative indications

Arrhythmias other than sustained ventricular tachycardia, including multifocal ectopy, ventricular triplets, supraventricular tachycardia, and bradyarrhythmias that have the potential to become more complex or to interfere with hemodynamic stability

Bundle branch block that cannot immediately be distinguished from ventricular tachycardia

Claudication, fatigue, leg cramps, shortness of breath, or wheezing

Decrease in systolic blood pressure greater than 10 mm Hg (persistently below baseline) despite an increase in workload and without other evidence of ischemia

Exaggerated hypertensive response (systolic blood pressure > 250 mm Hg or diastolic blood pressure > 115 mm Hg)

Heart rate > 85% of age-predicted maximum

Increasing chest pain

Marked ST-segment displacement (horizontal or downsloping> 2 mm, measured 60 to 80 milliseconds after the J-point) in a patient with suspected ischemia


Adapted with permission from Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):882.

Table 4.

Indications for Termination of Exercise Stress Testing

Absolute indications

Central nervous system symptoms (e.g., ataxia, dizziness, near syncope)

Decrease in systolic blood pressure greater than 10 mm Hg despite an increase in workload and accompanied by other evidence of ischemia

Moderate to severe angina

Signs of poor perfusion (e.g., cyanosis, pallor) ST-segment elevation (> 1.0 mm) in leads without preexisting Q waves because of prior myocardial infarction (other than aVR, aVL, and V1)

Sustained ventricular tachycardia or other arrhythmia (including second- or third-degree atrioventricular block) that interferes with normal maintenance of cardiac output during exercise

Technical difficulties in monitoring electrocardiography or systolic blood pressure

The patient asks to stop

Relative indications

Arrhythmias other than sustained ventricular tachycardia, including multifocal ectopy, ventricular triplets, supraventricular tachycardia, and bradyarrhythmias that have the potential to become more complex or to interfere with hemodynamic stability

Bundle branch block that cannot immediately be distinguished from ventricular tachycardia

Claudication, fatigue, leg cramps, shortness of breath, or wheezing

Decrease in systolic blood pressure greater than 10 mm Hg (persistently below baseline) despite an increase in workload and without other evidence of ischemia

Exaggerated hypertensive response (systolic blood pressure > 250 mm Hg or diastolic blood pressure > 115 mm Hg)

Heart rate > 85% of age-predicted maximum

Increasing chest pain

Marked ST-segment displacement (horizontal or downsloping> 2 mm, measured 60 to 80 milliseconds after the J-point) in a patient with suspected ischemia


Adapted with permission from Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):882.

EVIDENCE SUMMARY

ST-segment elevation of more than 1 mm during stress identifies areas of ischemia in proximal coronary vasculature.25 ST-segment depression of more than 2 mm does not localize anatomic ischemia, but when combined with clinical symptoms of ischemia suggests CAD (Figure 1).3 The sooner ST-segment depression develops during testing and the longer it persists into recovery, the more severe the CAD.26 As exercise increases cardiac output, systolic BP should increase. Inability to increase systolic BP suggests left ventricular systolic dysfunction or CAD. A prospective study (n = 44,000) of men and women, including blacks, with a mean age of 53 years showed a strong association between decreasing exercise systolic BP response, all-cause death, and MI.27 The lower the patient's rise in systolic BP in response to exercise, the higher the incidence rate of MI per 1,000 person-years (increase of more than 20 mm Hg above baseline = 3.9 incidence rate [95% CI, 3.6 to 4.1], 1 to 20 mm Hg above baseline = 8.0 [95% CI, 7.0 to 9.1], and decrease from baseline = 12.5 [95% CI, 10.2 to 15.4]).27 Therefore, it is recommended that exercise stress testing be discontinued if systolic BP decreases by more than 10 mm Hg.

 Enlarge     Print

Figure 1. ST-segment depression during exercise. Downsloping of more than 2 mm is a relative indication for termination. (ECG = electrocardiography.)

Adapted with permission from Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):885.


Figure 1. ST-segment depression during exercise. Downsloping of more than 2 mm is a relative indication for termination. (ECG = electrocardiography.)

Adapted with permission from Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):885.

Conversely, a hypertensive response to moderate-intensity exercise (systolic BP greater than 210 mm Hg in men or greater than 190 mm Hg in women) indicates a 1.36-fold greater rate of cardiovascular events and mortality (95% CI, 1.02 to 1.83; P = .039).28 The AHA recommends termination of testing when systolic BP exceeds 250 mm Hg or when diastolic BP exceeds 115 mm Hg.3 Reaching 85% of the maximal predicted heart rate (220 minus age) is a measure of adequate diagnostic exercise stress testing, but the AHA recommends that it not be used in isolation to terminate testing.3 During exercise, the heart rate should increase by 10 beats per minute per 1 MET. Failure of the heart rate to increase and prolonged delay in returning to resting levels may affect prognosis and indicate CAD.

This article updates previous articles on this topic by Fletcher, et al.,29 and by Darrow.30

The opinions and assertions contained herein are the personal views of the authors and are not to be construed as official or as reflecting the views of the U.S. Armed Services or their medical departments.

Data Sources: A PubMed search was completed using the MeSH function with the key phrase exercise stress test combined with at least one of the following terms: coronary artery disease detection or prognosis, stress echocardiogram, myocardial perfusion imaging, and SPECT. The search included meta-analyses, randomized controlled trials, clinical trials, and reviews. Also searched were Essential Evidence Plus, the Cochrane Database of Systematic Reviews, and the websites of the U.S. Preventive Services Task Force and the American Heart Association. Search dates: April 2016 and May 2017.

The Authors

show all author info

KATHRYN K. GARNER, MD, is a faculty member at the National Capital Consortium Family Medicine Residency in Fort Belvoir, Va., and an assistant professor of family medicine at the Uniformed Services University of the Health Sciences, Bethesda, Md....

WILLIAM POMEROY, MD, is a staff cardiologist at Keesler Medical Center, Biloxi, Miss.

JAMES J. ARNOLD, DO, FACOFP, FAAFP, is the senior associate program director at the National Capital Consortium Family Medicine Residency and an assistant professor of family medicine at the Uniformed Services University of the Health Sciences.

Address correspondence to Kathryn K. Garner, MD, 2501 Capehart Rd., Offutt Air Force Base, NE 68113 (e-mail: kathryn.k.garner2.mil@mail.mil). Reprints are not available from the authors.

Author disclosure: No relevant financial affiliations.

REFERENCES

show all references

1. Wolk MJ, Bailey SR, Doherty JU, et al.; American College of Cardiology Foundation Appropriate Use Criteria Task Force. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;63(4):380–406....

2. Greenslade JH, Parsonage W, Ho A, et al. Utility of routine exercise stress testing among intermediate risk chest pain patients attending an emergency department. Heart Lung Circ. 2015;24(9):879–884.

3. Fletcher GF, Ades PA, Kligfield P, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873–934.

4. Napoli AM. The association between pretest probability of coronary artery disease and stress test utilization and outcomes in a chest pain observation unit. Acad Emerg Med. 2014;21(4):401–407.

5. Scott AC, Bilesky J, Lamanna A, et al. Limited utility of exercise stress testing in the evaluation of suspected acute coronary syndrome in patients aged less than 40 years with intermediate risk features. Emerg Med Australas. 2014;26(2):170–176.

6. U.S. Preventive Services Task Force. Final recommendation statement: coronary heart disease: screening with electrocardiography. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/coronary-heart-disease-screening-with-electrocardiography. Accessed October 9, 2016.

7. American Academy of Family Physicians. Clinical preventive service recommendation: coronary heart disease. https://www.aafp.org/patient-care/clinical-recommendations/all/coronary-heart-disease.html. Accessed October 9, 2016.

8. Young LH, Wackers FJ, Chyun DA, et al.; DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547–1555.

9. Banerjee A, Newman DR, Van den Bruel A, Heneghan C. Diagnostic accuracy of exercise stress testing for coronary artery disease: a systematic review and meta-analysis of prospective studies. Int J Clin Pract. 2012;66(5):477–492.

10. Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60(18):1828–1837.

11. Heijenbrok-Kal MH, Fleischmann KE, Hunink MG. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J. 2007;154(3):415–423.

12. Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation. 1989;80(1):87–98.

13. Tweet MS, Arruda-Olson AM, Anavekar NS, Pellikka PA. Stress echocardiography: what is new and how does it compare with myocardial perfusion imaging and other modalities? Curr Cardiol Rep. 2015;17(6):43.

14. Dowsley T, Al-Mallah M, Ananthasubramaniam K, Dwivedi G, McArdle B, Chow BJ. The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making. Can J Cardiol. 2013;29(3):285–296.

15. Christian TF, Miller TD, Bailey KR, Gibbons RJ. Exercise tomographic thallium-201 imaging in patients with severe coronary artery disease and normal electrocardiograms. Ann Intern Med. 1994;121(11):825–832.

16. Miller TD, Askew JW, Anavekar NS. Noninvasive stress testing for coronary artery disease. Cardiol Clin. 2014;32(3):387–404.

17. Shaw LJ, Mieres JH, Hendel RH, et al.; WOMEN Trial Investigators. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) trial. Circulation. 2011;124(11):1239–1249.

18. Duvall WL, Savino JA, Levine EJ, Hermann LK, Croft LB, Henzlova MJ. Prospective evaluation of a new protocol for the provisional use of perfusion imaging with exercise stress testing. Eur J Nucl Med Mol Imaging. 2015;42(2):305–316.

19. Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med. 1987;106(6):793–800.

20. Bourque JM, Charlton GT, Holland BH, Belyea CM, Watson DD, Beller GA. Prognosis in patients achieving ≥ 10 METS on exercise stress testing: was SPECT imaging useful? J Nucl Cardiol. 2011;18(2):230–237.

21. Peterson PN, Magid DJ, Ross C, et al. Association of exercise capacity on treadmill with future cardiac events in patients referred for exercise testing. Arch Intern Med. 2008;168(2):174–179.

22. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801.

23. Fine NM, Pellikka PA, Scott CG, Gharacholou SM, McCully RB. Characteristics and outcomes of patients who achieve high workload (≥ 10 metabolic equivalents) during treadmill exercise echocardiography. Mayo Clin Proc. 2013;88(12):1408–1419.

24. de Liefde II, Hoeks SE, van Gestel YR, et al. Prognostic value of hypotensive blood pressure response during single-stage exercise test on long-term outcome in patients with known or suspected peripheral arterial disease. Coron Artery Dis. 2008;19(8):603–607.

25. Beinart R, Matetzky S, Shechter M, et al. Stress-induced ST-segment elevation in patients without prior Q-wave myocardial infarction. J Electrocardiol. 2008;41(4):312–317.

26. Goldschlager N, Selzer A, Cohn K. Treadmill stress tests as indicators of presence and severity of coronary artery disease. Ann Intern Med. 1976;85(3):277–286.

27. O'Neal WT, Qureshi WT, Blaha MJ, Keteyian SJ, Brawner CA, Al-Mallah MH. Systolic blood pressure response during exercise stress testing: the Henry Ford ExercIse Testing (FIT) Project. J Am Heart Assoc. 2015;4(5):1–8.

28. Schultz MG, Otahal P, Cleland VJ, Blizzard L, Marwick TH, Sharman JE. Exercise-induced hypertension, cardiovascular events, and mortality in patients undergoing exercise stress testing: a systematic review and meta-analysis. Am J Hypertens. 2013;26(3):357–366.

29. Fletcher GF, Mills WC, Taylor WC. Update on exercise stress testing. Am Fam Physician. 2006;74(10):1749–1756.

30. Darrow MD. Ordering and understanding the exercise stress test. Am Fam Physician. 1999;59(2):401–410.

 

 

Copyright © 2017 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


More in Pubmed

MOST RECENT ISSUE


Dec 1, 2018

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article